JPH0475052B2 - - Google Patents
Info
- Publication number
- JPH0475052B2 JPH0475052B2 JP58067296A JP6729683A JPH0475052B2 JP H0475052 B2 JPH0475052 B2 JP H0475052B2 JP 58067296 A JP58067296 A JP 58067296A JP 6729683 A JP6729683 A JP 6729683A JP H0475052 B2 JPH0475052 B2 JP H0475052B2
- Authority
- JP
- Japan
- Prior art keywords
- membrane
- block copolymer
- membranes
- molecular weight
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920001400 block copolymer Polymers 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000010521 absorption reaction Methods 0.000 claims description 13
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 12
- 238000001631 haemodialysis Methods 0.000 claims description 10
- 230000000322 hemodialysis Effects 0.000 claims description 10
- 238000002074 melt spinning Methods 0.000 claims description 9
- 239000012528 membrane Substances 0.000 description 61
- 238000000034 method Methods 0.000 description 33
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 30
- 239000012510 hollow fiber Substances 0.000 description 29
- -1 polyethylene terephthalate-polyethylene Polymers 0.000 description 19
- 230000035699 permeability Effects 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 239000000126 substance Substances 0.000 description 12
- 229920001059 synthetic polymer Polymers 0.000 description 12
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 229920002292 Nylon 6 Polymers 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 230000024203 complement activation Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920001281 polyalkylene Polymers 0.000 description 6
- 230000005856 abnormality Effects 0.000 description 5
- 230000002489 hematologic effect Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229920001477 hydrophilic polymer Polymers 0.000 description 4
- 201000002364 leukopenia Diseases 0.000 description 4
- 231100001022 leukopenia Toxicity 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 2
- 229920000299 Nylon 12 Polymers 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000002429 anti-coagulating effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 1
- DEUJSGDXBNTQMY-UHFFFAOYSA-N 1,2,2-trifluoroethanol Chemical compound OC(F)C(F)F DEUJSGDXBNTQMY-UHFFFAOYSA-N 0.000 description 1
- KLSLSJCKZBGUAJ-UHFFFAOYSA-N 4-[1-(4-carboxyphenoxy)ethoxy]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1OC(C)OC1=CC=C(C(O)=O)C=C1 KLSLSJCKZBGUAJ-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000000989 Complement System Proteins Human genes 0.000 description 1
- 108010069112 Complement System Proteins Proteins 0.000 description 1
- 229920005682 EO-PO block copolymer Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920000571 Nylon 11 Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920000402 bisphenol A polycarbonate polymer Polymers 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- YWJUZWOHLHBWQY-UHFFFAOYSA-N decanedioic acid;hexane-1,6-diamine Chemical compound NCCCCCCN.OC(=O)CCCCCCCCC(O)=O YWJUZWOHLHBWQY-UHFFFAOYSA-N 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- ONIHPYYWNBVMID-UHFFFAOYSA-N diethyl benzene-1,4-dicarboxylate Chemical compound CCOC(=O)C1=CC=C(C(=O)OCC)C=C1 ONIHPYYWNBVMID-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001692 polycarbonate urethane Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6729683A JPS59193102A (ja) | 1983-04-16 | 1983-04-16 | 選択透過性中空糸 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6729683A JPS59193102A (ja) | 1983-04-16 | 1983-04-16 | 選択透過性中空糸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59193102A JPS59193102A (ja) | 1984-11-01 |
| JPH0475052B2 true JPH0475052B2 (zh) | 1992-11-27 |
Family
ID=13340883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6729683A Granted JPS59193102A (ja) | 1983-04-16 | 1983-04-16 | 選択透過性中空糸 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59193102A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0781795A2 (en) | 1995-12-26 | 1997-07-02 | Teijin Limited | Application of sulfone, ketone and ester containing polyalkyl ethers to medical materials |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE443584B (sv) * | 1985-03-07 | 1986-03-03 | Gambro Dialysatoren | Sett att framstella en semipermeabel halfiber |
| JPH0628713B2 (ja) * | 1986-02-28 | 1994-04-20 | ダイセル化学工業株式会社 | 親水化ポリスルホン膜 |
| US5137635A (en) * | 1990-06-26 | 1992-08-11 | Terumo Kabushiki Kaisha | Permeable membrane excellent in biocompatibility |
| WO1995001218A1 (en) * | 1993-06-30 | 1995-01-12 | Biomedical Sensors, Ltd. | Biphasic material |
| US5608164A (en) * | 1995-07-27 | 1997-03-04 | The Babcock & Wilcox Company | Electromagnetic acoustic transducer (EMAT) for ultrasonic inspection of liquids in containers |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4971076A (zh) * | 1972-09-21 | 1974-07-09 | ||
| JPS5170190A (ja) * | 1974-12-17 | 1976-06-17 | Mitsubishi Petrochemical Co | Kotokaseimaku |
| JPS5424987A (en) * | 1977-07-27 | 1979-02-24 | Teijin Ltd | Photopolymerizable composition |
| JPS551887A (en) * | 1979-04-09 | 1980-01-09 | Toyobo Co Ltd | Preparing membrane by removing component from multiple component material |
| JPS584810A (ja) * | 1982-03-26 | 1983-01-12 | Toyobo Co Ltd | 微孔性中空繊維 |
-
1983
- 1983-04-16 JP JP6729683A patent/JPS59193102A/ja active Granted
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4971076A (zh) * | 1972-09-21 | 1974-07-09 | ||
| JPS5170190A (ja) * | 1974-12-17 | 1976-06-17 | Mitsubishi Petrochemical Co | Kotokaseimaku |
| JPS5424987A (en) * | 1977-07-27 | 1979-02-24 | Teijin Ltd | Photopolymerizable composition |
| JPS551887A (en) * | 1979-04-09 | 1980-01-09 | Toyobo Co Ltd | Preparing membrane by removing component from multiple component material |
| JPS584810A (ja) * | 1982-03-26 | 1983-01-12 | Toyobo Co Ltd | 微孔性中空繊維 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0781795A2 (en) | 1995-12-26 | 1997-07-02 | Teijin Limited | Application of sulfone, ketone and ester containing polyalkyl ethers to medical materials |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59193102A (ja) | 1984-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100432463B1 (ko) | 폴리술폰 중공사 반투막 | |
| US5258149A (en) | Process of making a membrane for high efficiency removal of low density lipoprotein-cholesterol from whole blood | |
| EP0568045B1 (en) | Polysulfone-based hollow fiber membrane and process for manufacturing the same | |
| US7441666B2 (en) | Process for producing an asymmetric porous film | |
| JP3117575B2 (ja) | ポリスルホン系中空繊維膜とその製造方法 | |
| JP4587079B2 (ja) | 改良された分離挙動を有する高流束透析膜 | |
| JP5074040B2 (ja) | 改良された中分子除去性を有する透析膜 | |
| AU660425B2 (en) | High efficiency removal of low density lipoprotein-cholesterol from whole blood | |
| US5187010A (en) | Membrane having high affinity for low density lipoprotein-cholesterol from whole blood | |
| WO1997034687A1 (fr) | Membrane en fils creux utilisee pour l'epuration du sang et epurateur de sang | |
| JP4265701B2 (ja) | ポリスルホン系多孔質膜 | |
| JP3366040B2 (ja) | ポリスルホン系半透膜およびその製造方法 | |
| JP3617194B2 (ja) | 選択透過性分離膜及びその製造方法 | |
| JP3714686B2 (ja) | ポリスルホン系中空糸膜及びその製造方法 | |
| JPH0475052B2 (zh) | ||
| US4181606A (en) | Lactam terpolymer membranes | |
| JPH10230148A (ja) | 半透膜 | |
| JP3934340B2 (ja) | 血液浄化器 | |
| JP2703266B2 (ja) | ポリスルホン中空繊維膜およびその製法 | |
| JPH0611320B2 (ja) | 血液透析用中空糸膜 | |
| JPH09308685A (ja) | 血液浄化用中空糸膜及び血液浄化器 | |
| JP3334705B2 (ja) | ポリスルホン系選択透過性中空糸膜 | |
| US4274965A (en) | Lactam terpolymer membranes | |
| JP4386607B2 (ja) | ポリスルホン系血液浄化膜の製造方法およびポリスルホン系血液浄化膜 | |
| JPH09308684A (ja) | 選択分離膜 |